08.22.25 -- Navigating the CDMO Frenzy For GLP-1 Services

Join this expert-led Pace webinar to gain a clear, step-by-step strategy for managing extractables and leachables (E&L) risk. Discover how to assess materials, assign risk scores, and reduce testing burdens—all while staying aligned with USP requirements. Whether you're launching new products or prepping for regulatory submissions, this session will streamline your approach. Secure your spot today! Click here to learn more.

Leveraging a CDMO to oversee all aspects of analytical method development is crucial for achieving speed in clinical trials, regulatory approval, and commercial launch.

Explore the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

Watch as experts provide insight into the challenges of HPAPI manufacturing and offer proven strategies for achieving the flexibility required for small-batch production.

A new study reveals a shocking truth: only 17% of pharmaceutical companies — including many CDMOs — have implemented automated controls to prevent sensitive data from leaking through AI tools.

Review how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.

Observe how a compound library uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.

Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

Our team of 1,000+ employees operates across two continents, seamlessly integrating expertise in drug product development, manufacturing, and clinical pharmacology.

ArQ Vita can achieve large volume, deep intramuscular delivery, making it the ideal platform to deliver medication for chronic conditions.

Accelerate your pharmaceutical development with end-to-end support, global softgel expertise, and the strategic advantages of a New Zealand-based manufacturing partner.